Enhancement of the aqueous solubility and masking the bitter taste of famotidine using drug/SBE-β-CyD/povidone K30 complexation approach
Article first published online: 12 APR 2010
DOI: 10.1002/jps.22153
Copyright © 2010 Wiley-Liss, Inc.
Additional Information
How to Cite
Mady, F. M., Abou-Taleb, A. E., Khaled, K. A., Yamasaki, K., Iohara, D., Ishiguro, T., Hirayama, F., Uekama, K. and Otagiri, M. (2010), Enhancement of the aqueous solubility and masking the bitter taste of famotidine using drug/SBE-β-CyD/povidone K30 complexation approach. Journal of Pharmaceutical Sciences, 99: 4285–4294. doi: 10.1002/jps.22153
Publication History
- Issue published online: 18 AUG 2010
- Article first published online: 12 APR 2010
- Manuscript Accepted: 23 FEB 2010
- Manuscript Revised: 14 JAN 2010
- Manuscript Received: 4 NOV 2009
- Abstract
- Article
- References
- Cited By
Keywords:
- famotidine;
- cyclodextrins;
- sulfobutyl ether β-cyclodextrin;
- Povidone K30;
- dissolution;
- masking of bitter taste
Abstract
The objective of the present study was to evaluate the potential of ternary system (comprised of famotidine, β-cyclodextrin (β-CyD) or its derivatives and a hydrophilic polymer) as an approach for enhancing the aqueous solubility and masking the bitter taste of famotidine. The aqueous solubility of famotidine increased in the presence of β-CyDs, particularly sulfobutyl ether β-CyD (SBE-β-CyD), and it was further enhanced by the combination of SBE-β-CyD and polyvinyl pyrrolidone (Povidone) K30. The solid binary (drug-β-CyDs) and ternary (drug-β-CyDs-Povidone K30) systems were prepared by the kneading and freeze-drying methods. The dissolution rates of these solid systems were much faster than that of the drug alone. A taste perception study was carried out, initially using a taste sensory machine and subsequently on human volunteers to evaluate the taste masking ability of the ternary complexation. Our results indicated that the combination of SBE-β-CyD and Povidone K30 is effective not only in the enhancement of the solubility and dissolution rate of famotidine, but also in masking of the bitter taste of the drug. This technique may be of value for the pharmaceutical industries, especially in preparation of rapidly disintegrating tablets dealing with bitter drugs to improve patient compliance and thus effective pharmacotherapy. © 2010 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 99:4285–4294, 2010

1520-6017/asset/JPS_left.gif?v=1&s=becd26fac43b87042ad04af68bbe20d6a12e64fc)
1520-6017/asset/olbannerright.jpg?v=1&s=254f44b422de0f476861bd1056a1789033e2171c)
1520-6017/asset/cover.gif?v=1&s=e589ccf35fd012c675e943835781318cb8666bed)